Ingredients | Amount Per Serving |
---|---|
(D-Ribose, Powder)
|
|
(D-Ribose, Powder)
|
750 mg |
None
Below is general information about the effectiveness of the known ingredients contained in the product D-Ribose 750 mg Unflavored. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
INSUFFICIENT RELIABLE EVIDENCE to RATE
Below is general information about the safety of the known ingredients contained in the product D-Ribose 750 mg Unflavored. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
LIKELY SAFE ...when used in amounts commonly found in food. Consuming ribose up to 36 mg/kg daily from food sources is considered safe by the European Food Safety Authority (103292). ...when used orally and appropriately, short-term (15218,15723,15724,15725,15726,15727,15728,15729,15730). Ribose has been used safely at doses up to 15 grams daily for up to 12 weeks (15218,15725,15727,15730,71601,100680,103291,108959). ...when used intravenously and appropriately, short-term (5662,5663,5676,5680,71603). There is insufficient reliable information available about the safety of ribose when used long-term.
PREGNANCY AND LACTATION:
Insufficient reliable information available; avoid using.
Below is general information about the interactions of the known ingredients contained in the product D-Ribose 750 mg Unflavored. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Theoretically, taking ribose in combination with antidiabetes drugs might increase the risk of hypoglycemia.
Details
|
Theoretically, taking ribose with insulin could increase the hypoglycemic effect of insulin.
Details
|
Below is general information about the adverse effects of the known ingredients contained in the product D-Ribose 750 mg Unflavored. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
General
...Orally and intravenously, ribose is generally well-tolerated for up to 1 month.
Most Common Adverse Effects:
Orally: Diarrhea, gastrointestinal discomfort, headache, hypoglycemia, nausea.
Intravenously: Hypoglycemia.
Endocrine
...Orally, ribose can decrease blood glucose levels (5667,92891).
In one pharmacokinetic study, fasting plasma glucose declined after single ribose doses of 2.5-10 grams. At all doses, serum glucose returned to near normal 2 hours post-administration but remained slightly below pre-dose levels for up to 5 hours. One case of symptomatic hypoglycemia 70 minutes post-dose was reported in a 53 kg female who took ribose 10 grams. The reaction was considered mild; however, specific blood glucose levels were not reported (92891).
Intravenously, ribose has been reported to cause hypoglycemia, increased serum insulin levels, and decreased serum phosphate (5650,5662,5663,5676).
Gastrointestinal ...Orally, ribose can cause diarrhea, gastrointestinal discomfort, and nausea (5664,5676,15218,92891). In one study, lowering the dose of ribose resolved the nausea (15218).
Neurologic/CNS ...Orally, ribose can cause headache (5664,92891). It has also been reported to cause a hyperanxious feeling, lightheadedness, increased appetite, and mild anxiety (15218). In one study, lowering the dose of ribose resolved the feeling of anxiety (15218).